CoChat

Efficacy of Caspofungin and Voriconazole Combinations in Experimental Aspergillosis

Open access
MacCallum, Donna M., Whyte, Julie A., Odds, Frank C. · 2005 · Antimicrobial Agents and Chemotherapy
Cited by 73

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Guinea pigs were infected with Aspergillus fumigatus at two challenge doses and treated for 7 days with a placebo, intraperitoneal caspofungin (1 mg/kg daily), oral voriconazole (1 mg/kg twice a day), or a combination of the caspofungin and voriconazole treatments. The combination therapy statistically significantly prolonged survival over that with the control at both challenge doses and achieved a statistically significant reduction in kidney burdens as measured by quantitative PCR. The same was true for animals given caspofungin alone at both levels of challenge and for animals treated with voriconazole alone at the lower challenge dose. However, the effects of combination therapy on prolongation of survival were greater than those of either monotherapy at both challenge doses, and the reduction in kidney burdens with combination therapy was significantly greater than that with caspofungin alone in the animals given the lower challenge dose. No synergistic interactive effects were seen for the two agents in checkerboard titration experiments in vitro. We conclude that therapy of experimental aspergillosis with caspofungin and voriconazole combined offers slight additional improvements in efficacy rather than effects of a clearly synergistic nature.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.49.9.3697-3701.2005

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Caspofungin: first approved agent in a new class of antifungals

    Johnson, M. D., & Perfect, J. R. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.5.807 · Cited by 85 · cited 1×

    “The clinical availability of two new antifungal agents, caspofungin and voriconazole, with different modes of action (10, 11) has heightened interest in combinations of antifungal agents as a means of improving outcomes in life-threatening fungal infections, particularly aspergillosis (4, 13, 14, 23).”
    Background

Show all 1 references

Cited by

See all 73

Metadata

Authors
MacCallum, D. M., Whyte, J. A., & Odds, F. C.
Venue
Antimicrobial Agents and Chemotherapy
Published
2005-09
Volume
49
Issue
9
Pages
3697-3701
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W2154515975
Cited by
73
References
1
FWCI
6.00
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of Caspofungin and Voriconazole Combinations in Experimental Aspergillosis. https://app.cochat.ai/papers/10.1128/aac.49.9.3697-3701.2005
The paper
MacCallum, D. M., Whyte, J. A., & Odds, F. C. (2005). Efficacy of Caspofungin and Voriconazole Combinations in Experimental Aspergillosis. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.49.9.3697-3701.2005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.